Logo

Pacific Edge Cxbladder Monitor

Dec 21, 2016

Pacific Edge has launched the Cxbladder Monitor, a urine-based gene expression test for investigation of bladder cancer in patients being monitored for recurrent disease. The test analyzes urine samples for expression genes, clinical, and patient variable factors that create unique molecular signatures for urothelial carcinoma. It is designed to be used on patients undergoing bladder cancer surveillance to determine if they have a low probability of having recurrence.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.